News provided by Breakthrough T1D, Formerly JDRF Apr 23, 2025, 11:00 AM ET The Breakthrough T1D U-M-OHSU Cardiorenal Center of Excellence to focus on heart and kidney disease in type 1 diabetes ...

More than a decade ago, researchers found that an acute complication of type 1 diabetes, diabetic ketoacidosis (DKA), can be resolved with the hormone leptin, even in the absence of insulin.

Semaglutide is a perfect GLP-1 to study first in type 1 diabetes because it has been approved for quite some time and has lots of important indications in type 2 diabetes that might pertain to ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related ...

More information: Trevor W. Reichman et al, Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes, New England Journal of Medicine (2025). DOI: 10.1056/NEJMoa2506549 ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related ...

Michels, A. W., et al. (2025) Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement. The Journal of Clinical Endocrinology ...

Comparing the data to studies in the U.S., the researchers found that 15 per cent of Black Americans diagnosed with type 1 diabetes had a form of the disease similar to the patients in Sub-Saharan ...

Obviously, that is not the case anymore,” Satish K. Garg, MD, professor of medicine and pediatrics at the Barbara Davis Center for Diabetes, University of Colorado Denver, said at the Advanced ...

Now, a clinical trial led by the Indiana University (IU) School of Medicine has shown that semaglutide improved blood glucose levels and weight loss in obese type 1 diabetics who use an automated ...